Filing Details
- Accession Number:
- 0001562180-21-001288
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-18 19:07:44
- Reporting Period:
- 2021-02-16
- Accepted Time:
- 2021-02-18 19:07:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1459839 | Si-Bone Inc. | SIBN | Surgical & Medical Instruments & Apparatus (3841) | 262216351 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1754765 | A Michael Pisetsky | C/O Si-Bone, Inc. 471 El Camino Real, Suite 101 Santa Clara CA 95050 | Gc & Chief Compliance Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-16 | 684 | $31.05 | 75,459 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-02-16 | 2,125 | $4.32 | 77,584 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-16 | 2,125 | $30.95 | 75,459 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-02-16 | 2,125 | $0.00 | 2,125 | $4.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,913 | 2026-07-26 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
- The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $30.77 to $31.23, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
- Includes 57,759 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.
Billionaire Hedge Funds
